LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy

Publisher: Spandidos Publications

E-ISSN: 1791-3004|10|6|2967-2972

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.10, Iss.6, 2014-01, pp. : 2967-2972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content